Gastrointestinal Stromal Tumor
📧 Sign up to get email alerts when something new happens for Gastrointestinal Stromal Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors [Phase 1]
Phase 1 dose-escalation study of TH-302 in combination with sunitinib for advanced renal cell carcinoma, gastrointestinal stromal tumors, an…
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: The Effects of Preoperative and Postoperative Oral Nutritional Supplements in Malnourished Post-gastrectomy Patients [NA]
A completed clinical trial evaluating the effects of preoperative and postoperative oral nutritional supplements in malnourished patients af…
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors [Phase 2]
Phase 2 trial evaluating AMG 706 (motesanib) for advanced gastrointestinal stromal tumors has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor [Phase 2]
Phase 2 trial update for regorafenib in patients with metastatic or unresectable gastrointestinal stromal tumor (GIST) completed with posted…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance [Phase 3]
A Phase 3 multicenter randomized study of imatinib (Glivec) in advanced gastrointestinal stromal tumors expressing C-kit was interrupted aft…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Perifosine + Sunitinib Malate for Patients With Advanced Cancers [Phase 1]
Phase 1 study evaluating perifosine in combination with sunitinib malate for patients with advanced cancers has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-21Clinical Trial Update: Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate [Phase 2]
This entry reports results from a Phase 2 trial evaluating sorafenib in patients with malignant gastrointestinal stromal tumor that progress…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas [Phase 2]
This is a completed Phase 2 trial of Nitrocamptothecin in patients with soft tissue sarcomas, including gastrointestinal stromal tumors and …
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Advanced/Metastatic Malignant GIST [Phase 2]
Completed Phase II trial evaluating therapy for locally advanced or metastatic soft tissue sarcoma and advanced/metastatic malignant gastroi…
-
CLINICAL_TRIALS trial_result · 2013-10-24Clinical Trial Update: Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors [NA]
A completed clinical trial evaluating how imatinib affects bone metabolism in patients with chronic myelogenous leukemia or gastrointestinal…
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery [Phase 3]
Phase 3 trial evaluating imatinib mesylate as adjuvant therapy for patients with primary gastrointestinal stromal tumor completely removed b…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor [Phase 2]
Phase 2 trial evaluating neoadjuvant and adjuvant imatinib mesylate for primary or recurrent malignant gastrointestinal stromal tumor (GIST)…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib
A completed non-interventional retrospective study evaluated the relationship between tumor mutational status and clinical benefit in Gastro…
-
CLINICAL_TRIALS trial_result · 2013-06-07Clinical Trial Update: A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib [Phase 2]
This document reports the completion of a Phase 2 study evaluating XL-820 in adults with advanced gastrointestinal stromal tumors resistant …
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery [Phase 2]
This Phase 2 trial evaluated oblimersen in combination with imatinib mesylate for advanced, unresectable gastrointestinal stromal tumors and…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor [Phase 2]
Phase 2 trial of temsirolimus (CCI-779) in soft tissue sarcoma and gastrointestinal stromal tumor has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-23Clinical Trial Update: The Effect of Food (High Fat and Low Fat Breakfast) on the Pharmacokinetics of Regorafenib [Phase 1]
This Phase 1 study assessed how a high-fat versus low-fat breakfast affects regorafenib pharmacokinetics; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib [Phase 1]
Phase 1 study CAMN107A2103 in gastrointestinal stromal tumors shows patients achieving stable disease, partial response, or complete respons…
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) [Phase 2]
This document reports the completion of a Phase 2 study evaluating AMG 706 in subjects with advanced gastrointestinal stromal tumors (GIST).…
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery [Phase 1]
Phase 1 trial evaluating the combination of doxorubicin hydrochloride and alvocidib in patients with metastatic or recurrent soft tissue sar…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery [Phase 2]
Phase 2 trial evaluating imatinib mesylate as adjuvant therapy after complete surgical resection of gastrointestinal stromal tumor; study co…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas [Phase 2]
A Phase 2 study of SU5416 in patients with advanced, metastatic, or recurrent soft tissue sarcomas, including gastrointestinal stromal tumor…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction [Phase 1]
This clinical trial update summarizes a Phase 1 study of Imatinib Mesylate in patients with advanced cancer and liver dysfunction, which has…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration [NA]
A completed clinical trial comparing a new core histology needle used for EUS-guided fine-needle biopsy with conventional fine-needle aspira…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors [Phase 2]
Phase 2 trial update of temozolomide in patients with unresectable or metastatic gastrointestinal stromal tumors (S9926) has completed.